Investors NewsSearch: Dec 13, 2022Rafael Holdings Reports First Quarter Fiscal 2023 Financial Results Nov 15, 2022Rafael Holdings to Focus on Strategic Business Development Initiatives and Curtail Early Stage Development Activities Oct 31, 2022Rafael Holdings Reports Fourth Quarter Fiscal 2022 Financial Results Aug 23, 2022Rafael Holdings Sells its Building Located at 520 Broad Street in Newark, New Jersey and Associated 800-Car Public Garage Jun 14, 2022Rafael Holdings Reports Third Quarter Fiscal 2022 Financial Results Mar 17, 2022Rafael Holdings Reports Second Quarter Fiscal 2022 Financial Results Jan 21, 2022William "Bill" Conkling to assume the role of Chief Executive Officer as of February 1, 2022 Dec 15, 2021Rafael Holdings Reports First Quarter Fiscal 2022 Financial and Operating Results Nov 22, 2021Rafael Holdings Realigns Leadership Team to Support Earlier Stage Pipeline Focus Oct 28, 2021Rafael Holdings Provides Update on Rafael Pharmaceuticals' Two Phase 3 Trials of CPI-613® (Devimistat), AVENGER 500 in Metastatic Pancreatic Cancer and ARMADA 2000 in Relapsed or Refractory Acute Myeloid Leukemia 1 2 3 4 5 6 << < > >>
